NCT00260923View on ClinicalTrials.gov

A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren in Patients With High Blood Pressure

PHASE3CompletedINTERVENTIONAL
Enrollment

641

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Hypertension
Interventions
DRUG

aliskiren

Trial Locations (2)

07936

Novartis Pharmaceuticals, East Hanover

Unknown

Investigative Centers

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY